Trial
NCT01159067
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
City of Hope Medical Center
Collaborators
—
Condition
Iron Overload
Intervention
deferasirox
Why stopped
Low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-18